Ignite Creation Date:
2025-12-24 @ 5:04 PM
Ignite Modification Date:
2026-01-02 @ 8:05 AM
Study NCT ID:
NCT01433250
Status:
COMPLETED
Last Update Posted:
2016-03-14
First Post:
2011-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2014-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-26
First Submit QC Date:
None
Study First Post Date:
2011-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-28
Results First Submit QC Date:
None
Results First Post Date:
2016-03-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-16
Last Update Post Date:
2016-03-14
Last Update Post Date Type:
ESTIMATED